Great Point Partners LLC Pliant Therapeutics, Inc. Transaction History
Great Point Partners LLC
- $121 Million
- Q2 2025
A detailed history of Great Point Partners LLC transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Great Point Partners LLC holds 850,000 shares of PLRX stock, worth $1.43 Million. This represents 0.82% of its overall portfolio holdings.
Number of Shares
850,000
Previous 850,000
-0.0%
Holding current value
$1.43 Million
Previous $1.15 Million
14.12%
% of portfolio
0.82%
Previous 0.71%
Shares
12 transactions
Others Institutions Holding PLRX
# of Institutions
127Shares Held
57.7MCall Options Held
245KPut Options Held
86.7K-
Tang Capital Management LLC San Diego, CA6MShares$10.1 Million0.42% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$8.35 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.95MShares$6.63 Million0.16% of portfolio
-
Morgan Stanley New York, NY3.75MShares$6.31 Million0.0% of portfolio
-
Chi Advisors LLC New York, NY3.01MShares$5.06 Million25.76% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $81.8M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...